PC
Perkins Capital Management Inc
13F filer · CIK 0000884300Reported Jul 24, 2026
Net seller this quarter
13F portfolio value$133MU.S. long equity reported on 13F
Positions784 new · 11 closed
Net flow last quarter-$10.6MBuys minus sells
Top 10 positions weight52.2%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 24, 202678 positions | |||||
| $11M | 8.29% | 0.03% | -8.3% | Q2 2018 | |
| $10.4M | 7.83% | 0.00% | -1.7% | Q3 2013 | |
| $8.08M | 6.07% | 0.00% | -10.3% | Q1 2018 | |
| $7.31M | 5.49% | Not reported | -6.8% | Q1 2025 | |
| $6.83M | 5.13% | 0.28% | -12.4% | Q3 2013 | |
| $6.49M | 4.88% | 3.47% | -11.6% | Q2 2018 | |
| $5.14M | 3.87% | 1.41% | -16.0% | Q2 2019 | |
| $5.11M | 3.84% | 0.01% | Not reported | Q3 2013 | |
| $4.9M | 3.68% | 0.51% | -8.9% | Q3 2022 | |
| $4.17M | 3.13% | 0.00% | -2.1% | Q1 2014 | |
| $3.52M | 2.65% | 0.07% | -20.4% | Q1 2018 | |
| $3.4M | 2.56% | 0.64% | -2.4% | Q4 2016 | |
| $3.2M | 2.41% | 0.22% | Not reported | Q3 2024 | |
| $3.14M | 2.36% | 0.39% | -1.7% | Q2 2016 | |
| $3.09M | 2.32% | 0.00% | Not reported | Q4 2018 | |
| $2.43M | 1.83% | 0.11% | -1.9% | Q3 2013 | |
| $1.87M | 1.41% | 0.07% | -17.3% | Q3 2020 | |
| $1.84M | 1.38% | 0.00% | -2.0% | Q1 2014 | |
| $1.74M | 1.31% | 2.46% | -0.2% | Q4 2022 | |
| $1.66M | 1.25% | 0.04% | -0.3% | Q2 2025 | |
| $1.61M | 1.21% | 0.09% | -16.9% | Q3 2013 | |
| $1.6M | 1.21% | 0.42% | +5.3% | Q1 2021 | |
| $1.6M | 1.20% | 0.08% | -0.3% | Q4 2025 | |
| $1.59M | 1.20% | 0.64% | +9.2% | Q3 2020 | |
| $1.52M | 1.14% | 0.11% | +2.0% | Q3 2013 | |
| $1.34M | 1.00% | 0.00% | -0.7% | Q3 2014 | |
| $1.24M | 0.93% | 2.29% | Not reported | Q4 2018 | |
| $1.2M | 0.91% | 0.59% | -0.1% | Q3 2025 | |
| $1.19M | 0.89% | 0.58% | -0.3% | Q2 2017 | |
| $1.1M | 0.83% | Not reported | Not reported | Q3 2025 | |
| $1.07M | 0.80% | 0.38% | +2.2% | Q1 2026 | |
| $1.03M | 0.78% | 3.07% | -3.1% | Q4 2019 | |
| $1.01M | 0.76% | 0.42% | -0.4% | Q3 2024 | |
| $998K | 0.75% | 1.13% | -0.3% | Q1 2026 | |
| $964K | 0.72% | 0.00% | -3.2% | Q4 2016 | |
| $912K | 0.69% | 0.00% | Not reported | Q1 2020 | |
| $855K | 0.64% | 0.00% | -1.9% | Q4 2020 | |
| $813K | 0.61% | 0.00% | -6.0% | Q3 2013 | |
| $803K | 0.60% | 0.07% | Not reported | Q3 2024 | |
| $767K | 0.58% | 0.00% | Not reported | Q3 2013 | |
| $760K | 0.57% | 0.31% | Not reported | Q4 2025 | |
| $746K | 0.56% | 0.00% | -1.6% | Q3 2013 | |
| $744K | 0.56% | 2.81% | -0.3% | Q3 2023 | |
| $700K | 0.53% | 4.11% | New | Q2 2026 | |
| $620K | 0.47% | 0.00% | -3.1% | Q4 2017 | |
| $611K | 0.46% | 0.37% | +0.4% | Q4 2025 | |
| $598K | 0.45% | 0.84% | Not reported | Q4 2025 | |
| $580K | 0.44% | 2.75% | -4.4% | Q4 2021 | |
| $507K | 0.38% | 0.00% | -4.6% | Q1 2017 | |
| $490K | 0.37% | 0.03% | -33.0% | Q3 2013 | |
| Q1 2026Reported Apr 23, 202685 positions | |||||
| $8.86M | 8.30% | 0.03% | -0.6% | Q2 2018 | |
| $8.12M | 7.61% | 0.00% | -1.5% | Q3 2013 | |
| $5.59M | 5.24% | 0.32% | -26.1% | Q3 2013 | |
| $5.45M | 5.11% | 0.01% | Not reported | Q3 2013 | |
| $4.23M | 3.96% | 0.00% | -6.6% | Q1 2014 | |
| $3.76M | 3.52% | Not reported | +0.8% | Q1 2025 | |
| $3.45M | 3.23% | 0.00% | Not reported | Q4 2018 | |
| $3.4M | 3.18% | 2.87% | +7.1% | Q4 2021 | |
| $3.15M | 2.96% | 0.00% | -12.2% | Q1 2018 | |
| $2.88M | 2.70% | 1.73% | +11.2% | Q2 2019 | |
| $2.82M | 2.64% | 0.11% | -10.6% | Q3 2013 | |
| $2.64M | 2.47% | 0.66% | -0.6% | Q4 2016 | |
| $2.43M | 2.27% | 0.09% | -0.1% | Q1 2018 | |
| $2.12M | 1.99% | 0.00% | -3.5% | Q1 2014 | |
| $1.87M | 1.75% | 0.11% | +0.1% | Q3 2013 | |
| $1.83M | 1.71% | 0.04% | -0.3% | Q2 2025 | |
| $1.68M | 1.58% | 0.40% | -0.4% | Q2 2016 | |
| $1.65M | 1.55% | 0.08% | -0.7% | Q4 2025 | |
| $1.57M | 1.47% | 0.40% | +13.4% | Q1 2021 | |
| $1.52M | 1.43% | 0.23% | Not reported | Q3 2024 | |
| $1.42M | 1.33% | 0.08% | -2.1% | Q3 2020 | |
| $1.29M | 1.21% | 0.68% | Not reported | Q3 2025 | |
| $1.23M | 1.16% | 0.73% | -8.3% | Q4 2019 | |
| $1.21M | 1.13% | 3.94% | -0.5% | Q2 2018 | |
| $1.2M | 1.13% | 0.60% | Not reported | Q3 2020 | |
| $1.17M | 1.10% | 0.56% | +21.6% | Q3 2022 | |
| $1.16M | 1.09% | 0.00% | -8.6% | Q3 2014 | |
| $1.14M | 1.07% | 17.10% | Not reported | Q3 2023 | |
| $1.01M | 0.95% | 0.00% | -3.8% | Q3 2013 | |
| $1.01M | 0.94% | 0.00% | -12.7% | Q1 2020 | |
| $982K | 0.92% | 0.10% | -6.7% | Q3 2013 | |
| $932K | 0.87% | 0.00% | -11.4% | Q4 2016 | |
| $920K | 0.86% | 0.37% | New | Q1 2026 | |
| $890K | 0.83% | Not reported | -1.1% | Q3 2025 | |
| $881K | 0.83% | 1.12% | New | Q1 2026 | |
| $879K | 0.82% | 3.17% | +1.5% | Q4 2019 | |
| $860K | 0.81% | 0.58% | -0.4% | Q2 2017 | |
| $800K | 0.75% | 2.54% | -0.6% | Q4 2022 | |
| $795K | 0.74% | 116.68% | -3.0% | Q4 2020 | |
| $750K | 0.70% | 1.11% | -0.7% | Q4 2025 | |
| $745K | 0.70% | 0.05% | -4.9% | Q3 2013 | |
| $742K | 0.70% | 0.00% | -5.2% | Q4 2020 | |
| $741K | 0.69% | 0.31% | Not reported | Q4 2025 | |
| $723K | 0.68% | 0.08% | Not reported | Q3 2024 | |
| $673K | 0.63% | 0.00% | -43.0% | Q3 2013 | |
| $653K | 0.61% | 0.00% | Not reported | Q3 2013 | |
| $649K | 0.61% | 0.44% | Not reported | Q3 2024 | |
| $640K | 0.60% | 0.00% | -7.6% | Q3 2024 | |
| $616K | 0.58% | 0.01% | -15.6% | Q1 2025 | |
| $603K | 0.57% | 0.03% | -7.1% | Q1 2017 | |
| Q4 2025Reported Feb 4, 202690 positions | |||||
| $10.2M | 8.10% | 0.03% | -0.7% | Q2 2018 | |
| $9.63M | 7.65% | 0.00% | -1.4% | Q3 2013 | |
| $7.47M | 5.93% | 0.48% | -3.3% | Q3 2013 | |
| $6.56M | 5.21% | 0.01% | Not reported | Q3 2013 | |
| $5.91M | 4.69% | 0.00% | -0.2% | Q1 2014 | |
| $4.92M | 3.91% | 2.68% | -1.7% | Q4 2021 | |
| $3.78M | 3.00% | 0.00% | -4.1% | Q1 2018 | |
| $3.61M | 2.87% | 0.11% | -0.9% | Q3 2013 | |
| $3.51M | 2.79% | Not reported | -0.1% | Q1 2025 | |
| $3.18M | 2.52% | 0.10% | -5.3% | Q1 2018 | |
| $2.68M | 2.13% | 0.00% | -0.7% | Q1 2014 | |
| $2.34M | 1.86% | 0.13% | -5.1% | Q3 2013 | |
| $2.14M | 1.70% | 0.66% | -2.8% | Q4 2016 | |
| $1.98M | 1.57% | 0.05% | -1.1% | Q2 2025 | |
| $1.98M | 1.57% | 0.09% | -7.2% | Q3 2020 | |
| $1.96M | 1.56% | 0.41% | -1.6% | Q2 2016 | |
| $1.9M | 1.51% | 0.23% | -5.4% | Q3 2024 | |
| $1.83M | 1.45% | 0.31% | -5.2% | Q1 2015 | |
| $1.67M | 1.32% | 0.11% | +3.7% | Q3 2013 | |
| $1.66M | 1.32% | 1.59% | +34.5% | Q2 2019 | |
| $1.65M | 1.31% | 0.38% | New | Q4 2025 | |
| $1.65M | 1.31% | 3.14% | +67.6% | Q4 2019 | |
| $1.47M | 1.17% | 0.00% | -33.0% | Q4 2018 | |
| $1.46M | 1.16% | 0.80% | +7.3% | Q4 2019 | |
| $1.45M | 1.15% | 3.98% | -12.8% | Q2 2018 | |
| $1.33M | 1.06% | 0.00% | Not reported | Q3 2014 | |
| $1.33M | 1.05% | 0.35% | +12.6% | Q1 2021 | |
| $1.3M | 1.03% | 0.48% | -0.5% | Q3 2022 | |
| $1.26M | 1.00% | 0.00% | Not reported | Q3 2013 | |
| $1.26M | 1.00% | 0.63% | +15.4% | Q3 2020 | |
| $1.25M | 0.99% | 0.08% | New | Q4 2025 | |
| $1.23M | 0.97% | 0.86% | -0.1% | Q3 2025 | |
| $1.2M | 0.95% | 0.35% | +24.3% | Q3 2025 | |
| $1.15M | 0.91% | Not reported | -1.7% | Q3 2025 | |
| $1.12M | 0.89% | 2.92% | +0.3% | Q3 2023 | |
| $1.09M | 0.87% | 0.09% | -0.4% | Q3 2019 | |
| $1.09M | 0.86% | 0.06% | -1.1% | Q3 2013 | |
| $1.01M | 0.81% | 0.00% | Not reported | Q1 2020 | |
| $960K | 0.76% | 2.55% | -17.7% | Q4 2022 | |
| $929K | 0.74% | 0.00% | -4.4% | Q3 2013 | |
| $921K | 0.73% | 0.00% | Not reported | Q4 2016 | |
| $899K | 0.71% | 0.31% | New | Q4 2025 | |
| $863K | 0.69% | 0.59% | +72.1% | Q2 2017 | |
| $817K | 0.65% | 0.19% | Not reported | Q2 2017 | |
| DODAWNDay One Biopharmaceuticals, Inc. | $783K | 0.62% | 0.08% | +2.1% | Q3 2025 |
| $721K | 0.57% | 0.01% | +0.4% | Q4 2020 | |
| $670K | 0.53% | 0.00% | -2.7% | Q3 2013 | |
| $666K | 0.53% | 0.04% | Not reported | Q1 2017 | |
| $638K | 0.51% | 0.01% | -19.0% | Q1 2025 | |
| $624K | 0.50% | 1.12% | New | Q4 2025 | |
| Q3 2025Reported Oct 31, 202582 positions | |||||
| $7.22M | 6.36% | 0.03% | -2.0% | Q2 2018 | |
| $6.94M | 6.11% | 0.00% | -4.5% | Q3 2013 | |
| $6.52M | 5.75% | 2.83% | -1.2% | Q4 2021 | |
| $6.34M | 5.59% | 0.00% | -0.3% | Q1 2014 | |
| $6.2M | 5.46% | 0.01% | Not reported | Q3 2013 | |
| $4.21M | 3.71% | 0.51% | -1.1% | Q3 2013 | |
| $2.98M | 2.62% | 0.00% | -4.7% | Q1 2018 | |
| $2.89M | 2.54% | 0.00% | -0.9% | Q1 2014 | |
| $2.86M | 2.52% | 0.09% | -2.9% | Q3 2020 | |
| $2.74M | 2.41% | 0.10% | -2.8% | Q1 2018 | |
| $2.67M | 2.35% | 0.13% | -0.8% | Q3 2013 | |
| $2.6M | 2.29% | 0.50% | -1.9% | Q3 2022 | |
| $2.52M | 2.22% | 0.12% | -3.6% | Q3 2013 | |
| $2.47M | 2.18% | 0.35% | -1.7% | Q1 2015 | |
| $2.39M | 2.11% | 0.33% | -2.3% | Q3 2024 | |
| $2.36M | 2.08% | 4.60% | -3.5% | Q2 2018 | |
| $2.25M | 1.98% | 0.68% | -1.8% | Q4 2016 | |
| $1.97M | 1.73% | 0.41% | +21.9% | Q2 2016 | |
| $1.78M | 1.57% | Not reported | +213.0% | Q1 2025 | |
| $1.66M | 1.46% | 0.75% | +37.0% | Q4 2019 | |
| $1.65M | 1.45% | 0.28% | Not reported | Q3 2024 | |
| $1.58M | 1.39% | 0.06% | -72.5% | Q2 2025 | |
| $1.37M | 1.21% | 0.01% | -2.6% | Q4 2018 | |
| $1.35M | 1.19% | 0.00% | -0.9% | Q3 2014 | |
| $1.3M | 1.15% | 17.61% | -2.1% | Q3 2023 | |
| $1.24M | 1.10% | 2.07% | -4.8% | Q4 2019 | |
| $1.24M | 1.09% | 1.22% | +1.0% | Q2 2019 | |
| $1.22M | 1.07% | 3.13% | -13.5% | Q4 2022 | |
| $1.18M | 1.04% | 0.00% | Not reported | Q3 2013 | |
| $1.18M | 1.04% | 0.27% | -4.5% | Q1 2021 | |
| $1.14M | 1.01% | Not reported | New | Q3 2025 | |
| $1.14M | 1.00% | 0.82% | New | Q3 2025 | |
| $1.1M | 0.97% | 0.55% | -1.0% | Q3 2020 | |
| $1.06M | 0.93% | 0.11% | -18.5% | Q3 2013 | |
| $1.01M | 0.89% | 174.43% | -2.0% | Q4 2020 | |
| $994K | 0.88% | 0.00% | -3.6% | Q3 2013 | |
| $978K | 0.86% | 0.06% | -4.7% | Q3 2013 | |
| $918K | 0.81% | 0.00% | -0.8% | Q1 2020 | |
| $800K | 0.71% | 0.00% | -6.6% | Q3 2013 | |
| $773K | 0.68% | 0.04% | Not reported | Q1 2017 | |
| $771K | 0.68% | 0.20% | -3.8% | Q2 2018 | |
| $751K | 0.66% | 0.34% | -1.4% | Q2 2017 | |
| $735K | 0.65% | 0.60% | Not reported | Q3 2013 | |
| $734K | 0.65% | 0.00% | Not reported | Q4 2016 | |
| $705K | 0.62% | 0.49% | +256.4% | Q4 2024 | |
| $641K | 0.56% | 0.10% | +0.5% | Q3 2019 | |
| $623K | 0.55% | 0.00% | -1.2% | Q3 2013 | |
| DODAWNDay One Biopharmaceuticals, Inc. | $580K | 0.51% | 0.08% | New | Q3 2025 |
| $571K | 0.50% | 0.00% | +1.4% | Q4 2020 | |
| $524K | 0.46% | 0.00% | Not reported | Q3 2019 | |
Premium opens every quarter this fund has filed